Pharmaceuticals Portfolio Mutual Fund Forward View - Price Action Indicator
| FPHAX Fund | USD 32.78 0.11 0.34% |
Pharmaceuticals Mutual Fund outlook is based on your current time horizon.
At this time the relative strength index (rsi) of Pharmaceuticals Portfolio's share price is below 20 . This usually indicates that the mutual fund is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Pharmaceuticals Portfolio hype-based prediction, you can estimate the value of Pharmaceuticals Portfolio Pharmaceuticals from the perspective of Pharmaceuticals Portfolio response to recently generated media hype and the effects of current headlines on its competitors.
Pharmaceuticals Portfolio after-hype prediction price | USD 32.78 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as fund price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Pharmaceuticals |
Pharmaceuticals Portfolio Additional Predictive Modules
Most predictive techniques to examine Pharmaceuticals price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pharmaceuticals using various technical indicators. When you analyze Pharmaceuticals charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Pharmaceuticals Portfolio Volatility | Backtest Pharmaceuticals Portfolio | Information Ratio |
Pharmaceuticals Portfolio Trading Date Momentum
| On February 16 2026 Pharmaceuticals Portfolio Pharmaceuticals was traded for 32.78 at the closing time. The highest daily price throughout the period was 32.78 and the lowest price was 32.78 . There was no trading activity during the period 0.0. Lack of trading volume on 02/16/2026 did not cause price change. The trading delta at closing time to current closing price is 0.00% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Pharmaceuticals Portfolio to competition |
Other Forecasting Options for Pharmaceuticals Portfolio
For every potential investor in Pharmaceuticals, whether a beginner or expert, Pharmaceuticals Portfolio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Pharmaceuticals Mutual Fund price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Pharmaceuticals. Basic forecasting techniques help filter out the noise by identifying Pharmaceuticals Portfolio's price trends.Pharmaceuticals Portfolio Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pharmaceuticals Portfolio mutual fund to make a market-neutral strategy. Peer analysis of Pharmaceuticals Portfolio could also be used in its relative valuation, which is a method of valuing Pharmaceuticals Portfolio by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Pharmaceuticals Portfolio Market Strength Events
Market strength indicators help investors to evaluate how Pharmaceuticals Portfolio mutual fund reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pharmaceuticals Portfolio shares will generate the highest return on investment. By undertsting and applying Pharmaceuticals Portfolio mutual fund market strength indicators, traders can identify Pharmaceuticals Portfolio Pharmaceuticals entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 32.78 | |||
| Day Typical Price | 32.78 | |||
| Price Action Indicator | 0.055 | |||
| Period Momentum Indicator | 0.11 |
Pharmaceuticals Portfolio Risk Indicators
The analysis of Pharmaceuticals Portfolio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Pharmaceuticals Portfolio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pharmaceuticals mutual fund prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.8599 | |||
| Semi Deviation | 0.8445 | |||
| Standard Deviation | 1.17 | |||
| Variance | 1.37 | |||
| Downside Variance | 1.23 | |||
| Semi Variance | 0.7131 | |||
| Expected Short fall | (0.98) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Pharmaceuticals Portfolio
The number of cover stories for Pharmaceuticals Portfolio depends on current market conditions and Pharmaceuticals Portfolio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pharmaceuticals Portfolio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pharmaceuticals Portfolio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Pharmaceuticals Mutual Fund
Pharmaceuticals Portfolio financial ratios help investors to determine whether Pharmaceuticals Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaceuticals with respect to the benefits of owning Pharmaceuticals Portfolio security.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |